{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:14:24Z","timestamp":1789802064802,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cgh.2022.06.015","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T19:12:10Z","timestamp":1657998730000},"page":"1503-1512.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2640-2211","authenticated-orcid":false,"given":"Jordan J.","family":"Feld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy C.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc G.","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Terrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Perrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Hinerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry LA.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna S.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.06.015_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-2006-939750","article-title":"Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment","volume":"26","author":"Feld","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2022.06.015_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2022.06.015_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2022.06.015_bib4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol 08"},{"key":"10.1016\/j.cgh.2022.06.015_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2022.06.015_bib7","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.immuni.2021.04.025","article-title":"Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage","volume":"54","author":"Barkaway","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cgh.2022.06.015_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2014.06.028","article-title":"Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype","volume":"13","author":"Ghany","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.06.015_bib10","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1128\/JCM.00813-10","article-title":"Robust hepatitis B virus genotyping by mass spectrometry. Comparative Study Evaluation Studies","volume":"48","author":"Ganova-Raeva","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cgh.2022.06.015_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/hep.31506","article-title":"Precore and basal core promoter hepatitis B virus (HBV) variants are present from a young age and differ across HBV genotypes","volume":"73","author":"Lau","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib12","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.31554","article-title":"Low incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy","volume":"73","author":"Lok","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/gutjnl-2017-314904","article-title":"High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B","volume":"67","author":"Kim","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.06.015_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.23348","article-title":"Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B","volume":"51","author":"Chen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib15","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.30417","article-title":"Entecavir and peginterferon alfa-2a in adults with hepatitis B e antigen-positive immune-tolerant chronic hepatitis B Virus infection","volume":"69","author":"Feld","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib16","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/hep.30312","article-title":"Combination of entecavir\/peginterferon alfa-2a in children with hepatitis B e antigen-positive immune tolerant chronic hepatitis B virus infection","volume":"69","author":"Rosenthal","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.06.015_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/apt.15741","article-title":"Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase","volume":"52","author":"Lee","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.06.015_bib18","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s41598-019-39043-2","article-title":"Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2022.06.015_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/jvh.13318","article-title":"HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis B","volume":"27","author":"Yuen","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2022.06.015_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cgh.2022.06.015_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00281-020-00806-z","article-title":"The interplay between immunosenescence and age-related diseases","volume":"42","author":"Barb\u00e9-Tuana","year":"2020","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.cgh.2022.06.015_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus--specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.06.015_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146883","article-title":"Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver","volume":"6","author":"Traum","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.cgh.2022.06.015_bib24","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jgh.12312","article-title":"Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination","volume":"28","author":"Wong","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.06.015_bib25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/MCG.0b013e318156feef","article-title":"Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT","volume":"42","author":"Wang","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2022.06.015_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jvh.12643","article-title":"Determination of hepatitis B phenotype using biochemical and serological markers","volume":"24","author":"Di Bisceglie","year":"2017","journal-title":"J\u00a0Viral Hepat"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200653X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200653X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:45:18Z","timestamp":1761543918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652200653X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S154235652200653X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.06.015","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}